Andropause - A debatable physiological process

JK Science

Volumn 8, Issue 2, 2006, Pages 68-72

  Verma, Punam ^a   Mahajan, K K ^a   Mittal, Sunita ^a  

^a HIMALAYAN INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FLUXOMESTERON; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LUTEINIZING HORMONE; METHYLTESTOSTERONE; PRASTERONE; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE DERIVATIVE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

AGING; ANDROGEN DEFICIENCY; ANDROPAUSE; BODY COMPOSITION; BONE MASS; BREAST TENDERNESS; CHEMICAL BURN; CLIMACTERIUM; COGNITION; COST EFFECTIVENESS ANALYSIS; DERMATITIS; DRUG CONTRAINDICATION; DRUG INDICATION; ERECTILE DYSFUNCTION; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HEMATOPOIESIS; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; LIBIDO; LIFE CYCLE; LIPID ANALYSIS; LIVER TOXICITY; MUSCLE STRENGTH; NOMENCLATURE; PATHOGENESIS; PROSTATE CANCER; REVIEW; SEXUAL BEHAVIOR; SLEEP APNEA SYNDROME; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL;

EID: 33746683104     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Tan RS, Philip PS. Perception of risk factor for andropause. Arch Androl 1999; 43: 227-33.
2. Morales L, Heaton JP, Carson CC. Andropause- a misnomer for true clinical entity. J Urol 2000; 163: 705-12.
3. Martin Du, Pan RC. Are the hormones of youth carcinogenic? Ann Endocrinol 1999; 60: 392-97.
4. Strenbach H. Age associated testosterone decline in men: clinical issue for psychiatry. Am J Psychiatry 2000; 157: 307-08.
5. Morales A. Androgen replacement therapy in hypogonadal ageing men. Expert Opin Pharmacother 2003; 4: 911-18.
6. Porterfield SP. Male reproductive systems. Endocrinology, 1st edn. Mosby 1997; 160-62.
7. Lund BC, Bever SKA, Perry PJ et al. Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly men. Pharmacother 1999; 19: 951-56.
8. McNaughton JA, Bangah ML, McCloud PI, Burger HG. Inhibin and age in men. Clin Endrocrinol 1991; 341-46.
9. Mankin HR, Lin T, Muruno EP, Osterman J. The aging Leydig cell: III Gonadotrophin stimulation in men. J Androl 1981; 2: 181-89.
10. Handelsman DJ. Androgen action and pharmacological uses. In: De Groot LJ (ed). Endocrinology, 4th edn, Vol. 3, WB Saunders company 2001; pp. 22-32.
11. Haeton JP, Morales A. Andropause- a multisystem disease. Can J Urol 2001; 8: 1213-22.
12. Prestwood KM. Diagnosis and management of osteoporosis in older adults. In: Humes HD ed. Kelly's TextBook of Internal Medicine 4th edn. Philadephia: Williams LC, Wilikins 2000. pp. 3076-77.
13. Marin P. Effects of androgens in men with the metabolic syndrome. Aging Male 1998; 129
14. Arver S, Dobs AS, Meilkle AW et al. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men. Clin Endocrinol 1997; 47: 727-37
15. Webb CM, McNeill JG, Hayward CS et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 1999; 19: 1690-96.
16. Sadar AM, Griffiths KA, Skilton MR, Wishart SM, Handelsman DJ, Celermajer DS. Physiological Testosterone replacement and arterial endothelial function in men. Clin Endocrinol 2003; 59: 62-67.
17. Basaria S, Dobs AS. Risks versus benefits of testosterone replacement in elderly men. Drugs Aging 1999; 15: 131-42.
18. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092-98.
19. Behre HM, Kliesch S, Leifke E, Link TM, Niesclag E. Long term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 2386-90.
20. Korenman SC, Moreley JE, Mooradian Ad et al. Secondary hypogonadism in older men: its relation to importance. J Clin Endocrinol Metab 1990; 71: 93-96.
21. Griggs RC, Pandya S, Florence JM et al. Randomized control trial of testosterone in myotonic dystrophy, Neurology 1989; 39: 219-22.
22. Bhasin S, Bagatell CJ, Bremner WJ et al. Issues in Issues in testosterone replacement in older men. J Clin Endocrinol Metab. 1998; 83: 3435-48.
23. Matsumoto AM, Sandblom RE, Schoene Rb et al. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnea, respiratory drives and sleep. Clin Endocrinol 1985; 22: 713-21.
24. Snyder PJ, Peachey H, Hannoush P et al. Effects of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 2647-53
25. Arver S, Dobs AS, Meikle AW et al Improvement of sexual function in testosterone difiencient men treated for on eyear with apermeation enhanced testosterone transdermal system. J Urol 1996; 155: 1604-08.
26. Morales A, Johnston B, Heaton JPW, Lundie M. Testosterone supplementation for hypogonadal impotence; assessment of biochemical measures and therapeutic outcomes. J Urol 1997; 157: 849-54.
27. Vogel W, Klaiber EL, Broverman DM. The role of the gonadal steroid hormones in psychiatric depression in men and women. Prog Neuropsychopharmacol 1978; 2: 487-90.
28. Burris AS, Banks SM, Carter CS et al. A long term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992; 13: 297-304.
29. Snyder PJ, Peachey H, Berlin JA et al. Effect of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000; 85: 2670-77.
30. McCarty MF, Vascular nitric oxide. Sex hormone replacement and fish oil may help to prevent Alzheimer's disease. Med Hypothesis 1999; 53: 369-74.
31. Gouras GK, Xu H, Gross RH et al. Testosterone reduces neuronal secretion of Alzheimer's b-amyloid peptides. Proc Nat Acad Sci 2000; 97: 1202-05.
32. Azad N, Pitale S, Barners W, Friedman N. Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab 2003; 88: 3064-68.
33. Carter HB, Pearson JD, Metter EJ et al. Longitudinal evalution of serum androgen levels in men with and without prostate 1995; 27: 25-31.
34. Douglas TH, Connelly R Mcleod DG et al. Effect of exogenous testosterone replacement on prostate specific androgen and prostate-specific membrane androgen levels in hypogonadal men. J Surg Oncol 1995; 59: 246.
35. Morley JE, Perry HM, Kaiser FE et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 1993; 41: 149-52.
36. Jin B, Turner L, Walters WAW, handelsman DJ. Androgen or estrogen effects on human prostate. J Clin Endocrinol Metab 1996; 81: 4290-95.